Singapore markets open in 4 hours 15 minutes
Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
5,048.42 -23.21 (-0.46%) Dow
38,085.80 -375.12 (-0.98%) Nasdaq
15,611.76 -100.99 (-0.64%) Bitcoin USD
64,858.75 +787.68 (+1.23%) CMC Crypto 200
1,396.60 +14.02 (+1.01%)
Wilmar International Limited (WLMIF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 12:31PM EDT
| Previous close | 2.6400 |
| Open | 2.6400 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 2.6400 - 2.6400 |
| 52-week range | 2.3000 - 3.1100 |
| Volume | |
| Avg. volume | 5,800 |
| Market cap | 16.481B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 11.00 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.13 (4.78%) |
| Ex-dividend date | 29 Apr 2024 |
| 1y target est | N/A |
- PR Newswire
Cerecin forges strategic partnership with A*STAR's Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders.
Cerecin Inc., a clinical-stage biotechnology company at the forefront of developing innovative neurotherapeutics, is pleased to announce the establishment of a Memorandum of Understanding (MOU) with A*STAR's Institute of Molecular and Cell Biology (IMCB). This collaboration aims to accelerate research and treatment initiatives for neurological disorders and diseases to enhance overall health and brain function.
© 2024 Yahoo. All rights reserved.